Dung H Nguyen, MD
Plastic and Reconstructive Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A94970 · Current
Licensed to practise in California · since 2006 · expires 2027-08-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$70,182
Medicare paid this office $70,182 for 118 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 47 | $6,961 | $122 |
| New patient visit (60+ min) | 30 | $4,306 | $144 |
| Long return visit (40+ min) | 28 | $3,476 | $116 |
Procedures Medicare counted
| Mastectomy | 47 | More than 94% of doctors who do this |
| Melanoma (skin cancer) excision | 1-10 | None |
Who their Medicare patients are
118 Original Medicare patients in 2024. Average age 69 · Also on Medicaid 17% · Health risk score 0.99. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: Cancer 75% · High blood pressure 49% · Depression 19% · Diabetes 14% · Chronic kidney disease 13% · Coronary heart disease 12%.
The office billed $723,251, Medicare allowed $90,011 and paid $70,182; for 223 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 118 | 223 | 69 | 0.99 | $723,251 | $70,182 |
| 2023 | 123 | 239 | 69 | 0.96 | $563,422 | $63,089 |
| 2022 | 112 | 334 | 68 | 1.27 | $720,924 | $79,136 |
| 2021 | 103 | 257 | 68 | 1.01 | $668,355 | $79,389 |
| 2020 | 89 | 176 | 69 | 1.04 | $395,365 | $49,977 |
| 2019 | 109 | 216 | 68 | 1.11 | $531,624 | $72,133 |
| 2018 | 119 | 326 | 71 | 1.66 | $610,840 | $85,121 |
| 2017 | 144 | 526 | 69 | 1.96 | $899,518 | $115,968 |
| 2016 | 104 | 297 | 70 | 2.05 | $553,888 | $74,216 |
| 2015 | 110 | 341 | 68 | 2.08 | $529,870 | $69,110 |
| 2014 | 56 | 177 | 68 | 1.44 | $443,564 | $53,631 |
| 2013 | 26 | 56 | 66 | 1.47 | $154,895 | $18,803 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 46 | $6,612 | $116 |
| New patient visit (60+ min) | 25 | $3,774 | $151 |
| Long return visit (40+ min) | 29 | $3,733 | $124 |
| Return visit (30+ min) | 14 | $1,265 | $84 |
2022: 6 services
| New patient visit (60+ min) | 43 | $6,495 | $151 |
| Long return visit (40+ min) | 37 | $4,835 | $110 |
| Graft using patient's fat removed by liposuction and inserted into trunk, breasts, scalp, arms, or legs, each additional 50.0 cc | 11 | $4,720 | $135 |
| Long return visit (40+ min) | 13 | $1,580 | $122 |
| Other procedure on blood vessel | 12 | $1,441 | $120 |
| Return visit (30+ min) | 14 | $1,173 | $78 |
2021: 4 services
| New patient visit (60+ min) | 36 | $5,873 | $163 |
| Long return visit (40+ min) | 34 | $4,499 | $118 |
| Long return visit (40+ min) | 16 | $2,114 | $111 |
| Return visit (30+ min) | 11 | $908 | $83 |
2020: 4 services
| New patient visit (60+ min) | 21 | $2,994 | $143 |
| Long return visit (40+ min) | 23 | $2,970 | $96 |
| Long return visit (40+ min) | 25 | $2,579 | $96 |
| Return visit (30+ min) | 12 | $959 | $69 |
2019: 5 services
| New patient visit (60+ min) | 32 | $4,803 | $150 |
| Long return visit (40+ min) | 35 | $3,611 | $88 |
| Long return visit (40+ min) | 17 | $2,108 | $96 |
| New patient visit (60+ min) | 12 | $1,563 | $130 |
| Return visit (30+ min) | 17 | $1,077 | $60 |
2018: 7 services
| New patient visit (60+ min) | 24 | $3,591 | $150 |
| New patient visit (60+ min) | 22 | $3,100 | $141 |
| Long return visit (40+ min) | 28 | $2,681 | $89 |
| Return visit (30+ min) | 21 | $1,761 | $65 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $1,663 | $49 |
| Long return visit (40+ min) | 15 | $1,603 | $89 |
| Return visit (30+ min) | 19 | $1,342 | $61 |
2017: 8 services
| New patient visit (60+ min) | 26 | $3,908 | $150 |
| Removal of skin and tissue, 20.0 sq cm or less | 28 | $3,837 | $50 |
| New patient visit (60+ min) | 24 | $3,548 | $148 |
| Long return visit (40+ min) | 25 | $2,980 | $96 |
| Long return visit (40+ min) | 19 | $2,138 | $93 |
| Return visit (30+ min) | 18 | $1,335 | $61 |
| Return visit (30+ min) | 13 | $1,058 | $71 |
| Injection of radioactive material for x-ray identification of lymph node | 11 | $475 | $34 |
2016: 5 services
| New patient visit (60+ min) | 29 | $4,212 | $145 |
| Long return visit (40+ min) | 14 | $1,685 | $99 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $1,359 | $54 |
| Return visit (30+ min) | 15 | $1,191 | $63 |
| Short return visit (20+ min) | 14 | $638 | $43 |
2015: 5 services
| New patient visit (45+ min) | 27 | $2,777 | $103 |
| New patient visit (60+ min) | 18 | $2,585 | $144 |
| Removal of skin and tissue, 20.0 sq cm or less | 24 | $2,381 | $54 |
| Short return visit (20+ min) | 41 | $2,152 | $41 |
| Return visit (30+ min) | 22 | $1,456 | $63 |
2014: 3 services
| New patient visit (45+ min) | 28 | $3,054 | $109 |
| Return visit (30+ min) | 15 | $1,035 | $69 |
| Short return visit (20+ min) | 15 | $1,001 | $46 |
2013: 1 service
| New patient visit (45+ min) | 12 | $1,240 | $103 |
Money from drug and device companies
$18,211 in 2025
| 2025 | 10 | 57 | $10,200 | $18,211 |
| 2024 | 5 | 27 | $1,275 | $4,754 |
| 2023 | 5 | 28 | None | $2,863 |
| 2022 | 4 | 13 | None | $630 |
| 2021 | 6 | 12 | None | $853 |
| 2020 | 4 | 8 | None | $569 |
| 2019 | 3 | 11 | None | $566 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ethicon | Ethilon | $11,960 | 11 payments
|
| Axogen | None | $3,091 | 12 payments
|
| Musculoskeletal Transplant Foundation | None | $1,510 | 9 payments
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $658 | 7 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $282 | 3 payments
|
| Ethicon US | Surgicel Nu-Knit | $156 | 2 payments
|
See all 49 published payments
| Becton Dickinson and | Meals · 2025-12-18 | Phasix Mesh | $25 |
| Axogen | Meals · 2025-12-18 | None | $17 |
| Musculoskeletal Transplant Foundation | Meals · 2025-12-17 | None | $112 |
| Axogen | Meals · 2025-12-17 | None | $17 |
| Abbvie | Meals · 2025-12-16 | Natrelle Saline-Filled Breast Implants | $147 |
| Ethicon | Consulting · 2025-12-15 | Ethilon | $850 |
| Abbvie | Meals · 2025-12-14 | Natrelle Saline-Filled Breast Implants | $144 |
| Axogen | Meals · 2025-12-11 | None | $18 |
| Axogen | Meals · 2025-12-04 | None | $83 |
| TELA Bio | Meals · 2025-11-26 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $83 |
| Abbvie | Meals · 2025-11-25 | Natrelle Saline-Filled Breast Implants | $9 |
| Musculoskeletal Transplant Foundation | Meals · 2025-11-25 | None | $58 |
| Musculoskeletal Transplant Foundation | Meals · 2025-11-25 | None | $206 |
| TELA Bio | Meals · 2025-11-17 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $56 |
| Becton Dickinson and | Meals · 2025-11-06 | Phasix Mesh | $127 |
| Ethicon US | Meals · 2025-10-31 | Surgicel Nu-Knit | $125 |
| Ethicon US | Meals · 2025-10-27 | Surgicel Nu-Knit | $31 |
| Axogen | Meals · 2025-10-27 | None | $83 |
| Axogen | Meals · 2025-10-23 | None | $6 |
| Axogen | Meals · 2025-10-23 | None | $14 |
| Musculoskeletal Transplant Foundation | Travel · 2025-10-22 | None | $402 |
| Musculoskeletal Transplant Foundation | Travel · 2025-10-22 | None | $190 |
| Musculoskeletal Transplant Foundation | Travel · 2025-10-15 | None | $181 |
| Musculoskeletal Transplant Foundation | Meals · 2025-10-08 | None | $119 |
| SOMAVAC Medical Solutions | Meals · 2025-09-22 | Somavac 100 Sustained Vacuum System | $136 |
| Axogen | Travel · 2025-09-21 | None | $722 |
| Axogen | Travel · 2025-09-21 | None | $1,540 |
| Axogen | Meals · 2025-09-21 | None | $287 |
| Axogen | Meals · 2025-09-21 | None | $150 |
| TELA Bio | Meals · 2025-08-29 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $143 |
| Ethicon | Consulting · 2025-08-20 | None | $9,350 |
| Abbvie | Meals · 2025-08-20 | Natrelle Saline-Filled Breast Implants | $100 |
| Musculoskeletal Transplant Foundation | Meals · 2025-08-20 | None | $67 |
| Ethicon | Travel · 2025-08-11 | None | $68 |
| Ethicon | Travel · 2025-08-08 | None | $75 |
| Ethicon | Travel · 2025-08-08 | None | $65 |
| Ethicon | Meals · 2025-08-07 | None | $260 |
| Ethicon | Travel · 2025-08-06 | None | $122 |
| Ethicon | Travel · 2025-08-04 | None | $6 |
| Ethicon | Travel · 2025-07-31 | None | $654 |
| Ethicon | Travel · 2025-07-30 | None | $462 |
| Ethicon | Travel · 2025-07-30 | None | $50 |
| Axogen | Meals · 2025-07-28 | None | $154 |
| Musculoskeletal Transplant Foundation | Meals · 2025-06-25 | None | $175 |
| Tactile Systems Technology | Meals · 2025-06-04 | Flexitouch Plus | $118 |
| Mentor Worldwide | Meals · 2025-05-22 | Mentor Memorygel Resterilizable Gel Sizer | $148 |
| Abbvie | Meals · 2025-05-10 | Natrelle Saline-Filled Breast Implants | $150 |
| Abbvie | Meals · 2025-04-01 | Natrelle Saline-Filled Breast Implants | $24 |
| Abbvie | Meals · 2025-03-21 | Natrelle Saline-Filled Breast Implants | $84 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $4,754
| Abbvie | Natrelle Saline-Filled Breast Implants | $4,301 | 19 payments
|
| Tactile Systems Technology | Flexitouch Plus | $149 | 3 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $146 | 3 payments
|
| MIMEDX Group | None | $133 | 1 payment
|
| Integra LifeSciences | Omnigraft | $26 | 1 payment
|
2023: $2,863
| Integra LifeSciences | Durasorb Monofilament Mesh | $1,259 | 5 payments
|
| Abbvie | Natrelle Saline-Filled Breast Implants | $593 | 9 payments
|
| Tactile Systems Technology | Flexitouch Plus | $585 | 7 payments
|
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $287 | 6 payments
|
| TELA Bio | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $139 | 1 payment
|
2022: $630
| Tactile Systems Technology | Flexitouch Plus | $274 | 4 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $215 | 4 payments
|
| Allergan | Natrelle Saline-Filled Breast Implants | $133 | 4 payments
|
| Musculoskeletal Transplant Foundation | None | $9 | 1 payment
|
2021: $853
| Stryker | Spy-Phi System | $260 | 2 payments
|
| Axogen | Avance Nerve Graft | $226 | 2 payments
|
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $215 | 3 payments
|
| Galderma Laboratories L.P. | None | $52 | 3 payments
|
| Tactile Systems Technology | Flexitouch Plus | $51 | 1 payment
|
| Allergan | Natrelle Saline-Filled Breast Implants | $50 | 1 payment
|
2020: $569
| Sientra | Sientra High Strength Cohesive Silicone Gel Breast Implant | $212 | 2 payments
|
| Allergan | Natrelle | $181 | 4 payments
|
| Axogen | Avance Nerve Graft | $91 | 1 payment
|
| Stryker | Spy Technology | $84 | 1 payment
|
2019: $566
| Allergan | Natrelle | $279 | 5 payments
|
| Axogen | Axoguard Nerve Protector | $212 | 4 payments
|
| Mentor Worldwide | Artoura Breast Tissue Expander | $75 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Mentor Worldwide LLC · A Study of the Safety and Effectiveness of the Mentor Larger Size Memorygel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction Or Revision Reconstruction · 2025 | Their institution | $36,481 |
| Mentor Worldwide LLC · A Study of the Safety and Effectiveness of the Mentor Larger Size Memorygel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction Or Revision Reconstruction · 2023 | Their institution | $20,310 |
| Mentor Worldwide LLC · A Study of the Safety and Effectiveness of the Mentor Larger Size Memorygel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction Or Revision Reconstruction · 2024 | Their institution | $4,332 |
| Mentor Worldwide LLC · A Study of the Safety and Effectiveness of the Mentor Larger Size Memorygel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction Or Revision Reconstruction · 2022 | Their institution | $1,929 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1760681191
- Licence
- CA A94970California A94970: Current · expires 2027-08-31
- Trained
- University of California, San Diego School of Medicine, 2004
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2007-07-16
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.